Honz Pharmaceutical Co., Ltd.

SZSE:300086 Stock Report

Market Cap: CN¥1.7b

Honz Pharmaceutical Past Earnings Performance

Past criteria checks 0/6

Honz Pharmaceutical's earnings have been declining at an average annual rate of -30.1%, while the Pharmaceuticals industry saw earnings growing at 9.2% annually. Revenues have been declining at an average rate of 11.5% per year.

Key information

-30.1%

Earnings growth rate

-30.1%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate-11.5%
Return on equity-4.2%
Net Margin-7.5%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Honz Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300086 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24670-5039119
31 Dec 237401235519
30 Sep 23638-9836231
30 Jun 23640-8433929
31 Mar 23600-12634028
01 Jan 23536-18837428
30 Sep 22600-5732012
30 Jun 22642-1936413
31 Mar 22760-539713
01 Jan 228371139815
30 Sep 21876-3442619
30 Jun 21934-5640917
31 Mar 21937-938817
31 Dec 20922937717
30 Sep 20877-2640219
30 Jun 20897-2540319
31 Mar 20913-6544618
31 Dec 191,008-2644317
30 Sep 191,008-3042414
30 Jun 191,131-1645715
31 Mar 199611534917
31 Dec 188831332417
30 Sep 189726032816
30 Jun 187106022018
31 Mar 187436623115
31 Dec 17668562129
30 Sep 17471551477
30 Jun 17463541550
31 Mar 17460431540
31 Dec 16471461530
30 Sep 16501701340
30 Jun 16512731460
31 Mar 16488931370
31 Dec 15410681430
30 Sep 15366571600
30 Jun 15370581590
31 Mar 15364451620
31 Dec 14409621610
30 Sep 14372311530
30 Jun 14338211430
31 Mar 14334191410
31 Dec 13309151380
30 Sep 13313261470
30 Jun 13329341530

Quality Earnings: 300086 is currently unprofitable.

Growing Profit Margin: 300086 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300086 is unprofitable, and losses have increased over the past 5 years at a rate of 30.1% per year.

Accelerating Growth: Unable to compare 300086's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 300086 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-0.8%).


Return on Equity

High ROE: 300086 has a negative Return on Equity (-4.22%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.